<< Вернуться к списку статей журнала

Том 3 №3 2001 год - Нефрология и диализ

Использование плазмафереза для коррекции реперфузионной травмы при пересадке почки

Каабак М.М. Горяйнов В.А. Дьяченко И.В.

Аннотация: Для профилактики реперфузионной травмы у 32 пациентов в течение первых 4 часов после реперфузии почечного аллотрансплантата был проведен сеанс плазмафереза. Оценивались частота отсроченной функции трансплантата, актуариальная выживаемость трансплантатов и пациентов, а также удельный прирост креатинина (мкмоль/л/сут). Полученные результаты сравнивались с двумя контрольными группами: 32 пациента, оперированных до начала исследования, и 31 пациент, оперированный после завершения исследования. Продемонстрировано существенное уменьшение доли трансплантатов с отсроченной функцией и улучшение отдаленных результатов в группе больных, получивших плазмаферез.

Для цитирования: Каабак М.М., Горяйнов В.А., Дьяченко И.В. Использование плазмафереза для коррекции реперфузионной травмы при пересадке почки. Нефрология и диализ. 2001. 3(3):345-353. doi:

Весь текст

Ключевые слова: трансплантация, почка, травма ишемии/реперфузии

Список литературы:

1. Ibrahim S., Jacobs F., Zukin Y., Enriquez D., Holt D., Baldwin W. 3rd, Sanfilippo F., Ratner L.E. Immunohistochemical manifestations of unilateral kidney ischemia. Clin Transplant; 1996; 10 (6 Pt 2): 646-652.
2. Shoskes D.A., Parfrey N.A., Halloran P.F. Increased major histocompatibility complex antigen expression in unilateral ishemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201-207.
3. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., Tilney N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 1; 99 (11): 2682-2690.
4. Salahudeen A., Wang C., McDaniel O., Lagoo-Denadyalan S., Bigler S., Barber H. Antioxidant lazaroid U-74006F improves renal function and reduces the expression of cytokines, inducible nitric oxide synthase, and MHC antigens in a syngeneic renal transplant model. Partial support for the response-to-injury hypothesis. Transplantation 1996; 15; 62 (11): 1628-1633.
5. Waddell T.K., Gorczynski R.M., DeCampos K.N., Patterson G.A., Slutsky A.S. Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg 1996; 62 (3): 866-872.
6. Koo D.D.H., Welsh K.I., McLaren A.J., Boake J.A., Morris P.J., Fuggle S. Cadaver versus living donor kidneys: Impact of donor factors on antigen induction before transplantation. Kidney International, 1999; 4 (56): 1551-1559.
7. Lu C.Y., Penfield J.G., Kielar M.L., Vazquez M.A., Jeyarajah D.R. Hypothesis: Is renal allоgraft rejection initiated by the response to injury sustained during the transplant process? Kidney International, 1999; 6 (55): 2157-2168.
8. Marcussen N., Lai R., Olsen T.S., Solez K. Morphometric and immunohistochemical investigation of renal biopsies from patients with transplant ATN, native ATN, or acute graft rejection. Transplant Proc 1996; 28: 470-476.
9. Porter K.A. Renal Transplantation, in Pathology of the Kidney / edited by R.H. Heptinstall, Boston, Little, Brown & Сo., 1992; 1799-1934.
10. Troppmann C., Gillinchtman A.B., Benedetti E., Almond P.S., Gruessner R.W., Najarian J.S., Matas A.J. Delayed graft function, acute rejection, and outcome after cadaveric renal transplantation: The multivariate analysis. Transplantation 1995; 59: 962-968.
11. Cosio F.G., Pelletier R.P., Falkenhain M.E., Henry M.L., Elkhammas E.A., Davies E.A., Bumgardner G.L., Ferguson R.M. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997; 63: 1611-1615.
12. Cecka J.M. The UNOS scientific renal transplant registry, in Clinical Transplantation 1996 / edited by J.M. Cecka, P. Terasaki, Los Angeles, UCLA Tissue Typing Laboratory, 1996; 1-14.
13. Land W., Messmer K. The impact of ishemia/reperfusion injury on specific and non-specific? Early and late chronic events after organ transplantation. Transplantation Rev 1996; 10: 108-127.
14. Pollak R., Andrisevic J.H., Maddux M.S., Gruber S.A., Paller M.S. A randomized double blind trial of the use of human recombinant superoxide dismutase in renal transplantation. Transplantation 1993; 55: 57-60.
15. Land W., Schneeberger H., Schleibner S.T., Illner W.D., Abendroth D., Rutili G., Arfors K.E., Messmer K. Beneficial effect of human recombinant superoxide dismutase on both acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211-217.
16. Kelly K.J., Williams W.W. Jr., Colvin R.B., Bonventre J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ishemic injury. Proc Natl Acad Sci USA 1995; 91: 812-816.
17. Isobe M., Yagita H., Okumura K., Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125-1127.
18. Hourmant M., Bedrossian J., Durand D., Lebranchu, Renoult E., Caudrelier P., Buffet R., Soulillou J.P. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globuline as induction treatment in first kidney transplantation. Transplantation 1996; 62: 1565-1570.
19. Haug C.E., Colvin R.B., Delmonico F.L., Auchincloss H. Jr., Tolkoff-Rubin N., Preffer F.I., Rothlein R., Norris S., Scharschmidt L., Cosimi A.B. A phase 1 trial of immunosupression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766-773.
20. Porter K.A. Renal Transplantation, in Pathology of the Kidney / edited by R.H. Heptinstall, Boston, Little, Brown & Co., 1992; 1799-1934.
21. Kramer A.A., Postler G., Salhab K.F., Mendez C., Carey L.C., Rabb H. Renal ishemia/reperfusion leads to macrophage-mediated increase in pulminary vascular permeability. Kidney Int 1999; 55: 2362-2367.
22. Ruschitzka F., Shaw S., Gycl D., Noll G., Barton M., Thomas F. Lüscher: Endothelial dysfunction in acute renal failure: role of circulating and tissue endothelin-1. J Am Soc Nephrol 1999; 10: 953-962.
23. Pagtalunan M.E., Olson J.L., Tilney N.L., Meyer T.W. Late consequences of acute ishemic injury to a solitary kidney. J Am Soc Nephrol 1999; 10; 9: 1940-1949.
24. Azuma H., Nadeau K., Takada M., Mackenzie H.S., Tilney N.L. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Transplantation 1997; 27; 64 (2): 190-197.
25. Takada M., Nadeau K.C., Shaw G.D., Tilney N.L. Prevention of late renal changes after initial ischemia/reperfusion injury by blocking early selectin binding. Transplantation 1997; 15; 64 (11): 1520-1525.
26. Chanraker A., Takada M., Nadeau K.C., Peach R., Tinley N., Sayegh M. CD28-B7 blockade in organ dysfunction secondary to cold ishemia/reperfusion injury. Kidney International 1997; 52:1678-1684.
27. Takada M., Chandraker A., Nadeau K.C., Sayegh M.H., Tilney N.L. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997; 1; 100 (5): 1199-1203.
28. Goes N., Urmos J., Ramassar V., Halloran P.F. Ishemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1: granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995; 59: 565-572.
29. Larsen C.P., Ritchie S.C., Hendrix R., Linsley P.S., Hathcock K.S., Hodes R.J., Pearson T.C. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208-5219.
30. Stefanidis I., Heintz B., Stocker G., Mrowka C., Sieberth H.G., Haubeck H.D. Association between heparan sulfate proteoglycan excretion and proteinuria after renal transplantation. J Am Soc Nephrol 1996; 7 (12): 2670-2676.
31. Banu N., Meyers C.M. INF-γ and LPS differentially modulate class II MHC and B7-1 expression on murine renal tubular epithelial cells. Kidney International Vol. 1999; 55: 2250-2263.
32. Hogaboam C., Snider D.P., Collins S.M. Citokine modulation of T-lymphocyte activation by intestinal smooth muscle cells. Gastroenterology 1997; 112: 1986-1995.
33. Melhus O., Koerner T.J., Adams D.O. Effects of TNF alpha on the expression of class II MHC molecules in macrophages induced by INF gamma: Evidence for suppression at the level of transcription. J leukoc Biol 1994; 49: 21-27.
34. Zizzi H.C., Zibari G.B., Granger D.N., Singh I., Cruz L.D., Abreo F., McDonald J.C., Brown M.F. Quantification of P-selectin expression after renal ischemia and reperfusion. J Pediatr Surg 1997; 32 (7): 1010-1013.
35. Strehlau J., Pavlakis M., Lipman M., Maslinski W., Shapiro M., Strom T.B. The intragraft gene activation of markers reflecting T-cell-activation and -cytotoxicity analyzed by quantitative RT-PCR in renal transplantation. Clin Nephrol 1996; 46 (1): 30-33.
36. Replacement of renal function by dialysis / edited by Claude Jacobs, Carl M. Kjellstrand, Karl M. Koch, James F. Winchester (editor-in-chief). Fourth edition. Kluwer academic publishers 1996.
37. Matthias Schneider. Plasmapheresis and immunoadsorption: Different techniques and their current role in medical therapy. Kidney International, 1998; 53; Suppl. 64, S-61-S-65.
38. Cockroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.

Другие статьи по теме

• Актуальные проблемы поздней дисфункции почечного аллотрансплантата
• Лечение реперфузионного синдрома при трансплантации почки путем проведения плазмафереза
• Применение мофетил-микофенолата у реципиентов аллогенных почек в различные сроки после трансплантации
• Выбор оптимального режима терапии Циклоспорином у реципиентов аллогенных почек в различные сроки после операции